Loading...

BCTX BRIACELL THERAPEUTICS CORP Earnings Reports 8-K Filing

BRCL

BCTX

BRIACELL THERAPEUTICS CORP

(BCTX)

2025 8-K

Financial Disclosure

Shareholder Meeting Results

Asset Acquisition

Capital Raising

Financial Update

Financial Report Filed

Share Consolidation

Equity Offerings

Financial Statements

Equity Offerings

Financial Filing

Nasdaq Compliance

Annual Meeting Results

Share Consolidation

Meeting Reschedule

Share Consolidation

Financial Filing

Public Offering

Director Resignation

Financial Disclosure

Clinical Trial Success

Positive Announcements

Financial Statements

Securities Purchase Agreements

Financial Statements

Annual General Meeting of S...

Financial Statements

Announcement of Phase 2 Stu...

Financial Statements and Ex...

Spin-out Transaction

Spin-out Transaction

Shareholder Meeting Results

FDA Approval for Bria-IMTTM...

Spin-off Agreement

Equity Issuance

Agreement and Stock Purchase

Clinical Data Presentation

Reorganization Plan

Promising Survival Data fro...

Amendment and Shareholder M...

Regulation FD Disclosure

Investigation Announcement

FDA Meeting Feedback

Patent Issuance and FDA Gui...

External Links:

On December 29, 2025, BriaCell Therapeutics Corp. reported the unaudited financial statements of its subsidiary, BriaPro Therapeutics Corp., for the three-month period ended October 31, 2025, including management’s discussion and analysis.

AI Assistant

BRIACELL THERAPEUTICS CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.